Lobbying ≠ campaign money. These LDA lobbying figures are a separate, unbridged channel from FEC campaign contributions; this platform does not yet link a lobbying registrant to any FEC committee. See the methodology glossary.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
Lobbying registrant · 27478
2 filings on record; a reported $590,000 in total across them. Honesty note: each amount is the registrant's reported lobbying income/spend for that quarter (a lump sum required by the Lobbying Disclosure Act, or LDA — the law governing public lobbying reports), so this total is a gross sum of quarterly figures. The filings do disclose which bills were lobbied on (below), but never how much of the money went to any one bill, and never whether the filer supported or opposed it.
Clients
Filings
| Client | Period | Reported quarterly amount | Filing type |
|---|---|---|---|
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | Q2 2026 | $270,000 | Q2 |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | Q1 2026 | $320,000 | Q1 |
Source: Senate LDA filings.
Bills lobbied on
Bills named in this registrant's filings. A titled link means the bill is in our corpus; a bare canonical reference means it is not.
- A concurrent resolution establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. (us-119-hconres-14)
- A bill to provide for reconciliation pursuant to title II of H. Con. Res. 14. (us-119-hr-1)
- A bill making further continuing appropriations and other extensions for the fiscal year ending September 30, 2025, and for other purposes. (us-119-hr-1968)
- us-119-hr-2214 (not in corpus)
- us-119-hr-2428 (not in corpus)
- Ensuring Community Access to Pharmacist Services Act (us-119-hr-3164)
- us-119-hr-4317 (not in corpus)
- us-119-hr-4409 (not in corpus)
- us-119-hr-5031 (not in corpus)
- us-119-hr-5133 (not in corpus)
- us-119-hr-5256 (not in corpus)
- us-119-hr-5304 (not in corpus)
- us-119-hr-5316 (not in corpus)
- us-119-hr-6400 (not in corpus)
- SAFE Drugs Act of 2025 (us-119-hr-6509)
- us-119-hr-6609 (not in corpus)
- Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] (us-119-hr-6610)
- Lower Health Care Premiums for All Americans Act (us-119-hr-6703)
- us-119-hr-6837 (not in corpus)
- A bill making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes. (us-119-hr-7148)
- us-119-hr-7895 (not in corpus)
- us-119-hr-8269 (not in corpus)
- PBM Act (us-119-hr-8779)
- National Defense Authorization Act for Fiscal Year 2027 (us-119-hr-8800)
- us-119-hres-805 (not in corpus)
- Cure Hepatitis C Act of 2025 (us-119-s-1941)
- us-119-s-2426 (not in corpus)
- us-119-s-2800 (not in corpus)
- us-119-s-3159 (not in corpus)
- us-119-s-3345 (not in corpus)
- us-119-s-3549 (not in corpus)
- CLEAR LABELS Act (us-119-s-3788)
- SAFE Drugs Act of 2026 (us-119-s-3794)
- us-119-s-3822 (not in corpus)
- Rx ACCESS Act (us-119-s-4106)
- us-119-s-4509 (not in corpus)
- National Defense Authorization Act for Fiscal Year 2027 (us-119-s-4784)
- us-119-s-526 (not in corpus)
- us-119-s-527 (not in corpus)
- us-119-s-587 (not in corpus)
- us-119-s-882 (not in corpus)
- us-119-s-891 (not in corpus)
- us-119-s-927 (not in corpus)
- An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. (us-119-sconres-7)
Bill references are free-text extractions from LDA specific_issues;
they show a bill was named in a quarter, not money spent on it.